Filing Details

Accession Number:
0001179110-13-012434
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-01 16:08:44
Reporting Period:
2013-07-30
Filing Date:
2013-08-01
Accepted Time:
2013-08-01 16:08:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130598 Onconova Therapeutics Inc. ONTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304250 S Henry Bienen C/O Onconova Therapeutics, Inc.
375 Pheasant Run
Newtown PA 18940
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-30 6,868 $0.00 6,868 No 4 C Direct
Common Stock Acquisiton 2013-07-30 6,667 $15.00 13,535 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series I Convertible Preferred Stock Disposition 2013-07-30 9,156 $0.00 6,868 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.